Chief Medical Officer Summit 360º
We are pleased to welcome Dr Julie Krop, CMO, EVP, Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals, Dr Zain Kassam, Co-Founder, EVP, Clinical Development and Translational Medicine, Finch Therapeutics and Dr Steven Zelenkofske, EVP, CMO, Achillion Pharmaceuticals as co-chairs for the 2020 CMO Summit.
Joining the Summit for the first time are Dr Jeremy Levin, who shares his journey as a physician leader in both large pharma and small biotech, and Milind Kamkolkar, Chief Data Officer, Cellarity, who shares his thoughts on the collective struggle to evolve a drug development organization’s data and analytics culture and capabilities.
Annual keynote speaker Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, is confirmed to provide his drug development zeitgeist talk.
This conference is dedicated to accomplishing two goals:
1) To bring together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.
2) To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.
Key Topic Areas for 2020
Leveraging Real-World Data and AI/ML to Optimize Clinical Development
The Evolving Role of a CMO from Pre- to Post-IPO
Recruiting, Retaining and Motivating Top-Level Talent
How to Serve What Seems Like Everybody in the CMO Role: Prioritizing Effectively
Creative Budgeting in an Increasingly Expensive Industry
Insourcing and Outsourcing as Your Company Evolves
The Changing R&D Landscape in the Biotech and Pharmaceutical Industry
Harmonizing Drug Development and Clinical Operations Across Different Continents and Countries
Career Development with Physician-Focused Career Coaches
Building Teams and Expanding Your Reach with Virtualization